Nath Bio-Genes Stock Price Analysis and Quick Research Report. Is Nath Bio-Genes an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Nath Bio-Genes. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Nath Bio-Genes has a PE ratio of 7.07997977503875 which is low and comparatively undervalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Nath Bio-Genes has ROA of 4.45% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Nath Bio-Genes has a Current ratio of 1.8745.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Nath Bio-Genes has a ROE of 6.6925%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Nath Bio-Genes has a Debt to Equity ratio of 0.1713 which means that the company has low proportion of debt in its capital.

• Sales growth: Nath Bio-Genes has reported revenue growth of 8.9239% which is poor in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Nath Bio-Genes for the current financial year is 14.463380752459%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Nath Bio-Genes is Rs 2 and the yield is 1.1713%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Nath Bio-Genes is Rs 24.1286. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Nath Bio-Genes in Ticker for free. Also, one can get the intrinsic value of Nath Bio-Genes by using Valuation Calculators, which are available with a Finology ONE subscription. 

Nath Bio-Genes FAQs

Q1. What is Nath Bio-Genes share price today?
Ans: The current share price of Nath Bio-Genes is Rs 170.83.

Q2. What is the market capitalisation of Nath Bio-Genes?
Ans: Nath Bio-Genes has a market capitalisation of Rs 324.645332 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Nath Bio-Genes?
Ans: The PE ratio of Nath Bio-Genes is 7.07997977503875 and the P/B ratio of Nath Bio-Genes is 0.474066879422783, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Nath Bio-Genes share?
Ans: The 52-week high share price of Nath Bio-Genes is Rs 238.69, and the 52-week low share price of Nath Bio-Genes is Rs 137.55.

Q5. Does Nath Bio-Genes pay dividends?
Ans: Currently, Nath Bio-Genes pays dividends. Dividend yield of Nath Bio-Genes is around 1.1713%.

Q6. What are the face value and book value of Nath Bio-Genes shares?
Ans: The face value of Nath Bio-Genes shares is Rs 10, while the book value per share of Nath Bio-Genes is around Rs 360.35. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Nath Bio-Genes?
Ans: Nath Bio-Genes has a total debt of Rs 111.1331 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Nath Bio-Genes?
Ans: The ROE of Nath Bio-Genes is 6.6925% and ROCE of Nath Bio-Genes is 7.2871%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Nath Bio-Genes a good buy for the long term?
Ans: The Nath Bio-Genes long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Nath Bio-Genes undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Nath Bio-Genes appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Nath Bio-Genes’s financials?
Ans: You can review Nath Bio-Genes’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.